Sudeep Pharma544619CEO role change
MD of wholly owned US subsidiary ceases to be Senior Management Personnel w.e.f. 2nd October 2026
Mr. Sendhil Pani, 'Managing Director' of Sudeep Pharma USA Inc. (a wholly owned subsidiary), has ceased to be a Senior Management Personnel (SMP) of the Company w.e.f. 2nd October 2026.
- Person
- Mr. Sendhil Pani
- Designation
- 'Managing Director' of Sudeep Pharma USA Inc. (a wholly owned subsidiary)
- Date of cessation as SMP
- 2nd October 2026
- Reason for change
- completion of contractual arrangements between the Company and Mr. Sendhil Pani
Who has changed
- The Company has informed the exchanges about a change in its Senior Management Personnel, or SMP.
- Mr. Sendhil Pani held the position of 'Managing Director' of Sudeep Pharma USA Inc., which is a wholly owned subsidiary of Sudeep Pharma Limited.
- He will no longer be associated with the Company as SMP. The update states he ceased to be SMP w.e.f. 2nd October 2026.
Why the change happened
- The stated reason is completion of contractual arrangements between the Company and Mr. Sendhil Pani.
- In other words, the arrangement between the Company and him has run its course, and with that his role as an SMP has ended.
The details shared in the annexure
- The reason for change is recorded as completion of contractual arrangements between the Company and Mr. Sendhil Pani.
- The date of cessation is given as 2nd October 2026.
- The remaining rows in the annexure, namely brief profile, disclosure of relationships between directors, and the disclosure under Clause 7C of Part A of Schedule III, are marked Not Applicable.
How a retail investor can read this
- An SMP is part of the senior leadership that a company is required to disclose changes to, so that shareholders know who is running the business.
- Here, the change is specific to a senior role linked to the Company's US subsidiary, and the Company has stated the reason for the exit.
- The Company has not linked this change to any other development, and the update deals only with this role change.
Source: BSE · 5 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.